POC development in a post-COVID-19 world
Hydrix recently undertook a market research initiative focusing on the in-vitro diagnostics/point-of-care (IVD/POC) market, engaging with key stakeholders in the…
News & Articles
How insights-driven innovation can transform your medical device strategy
In a post-COVID world, more than ever medical device development teams face complex challenges: shrinking or uncertain budgets, regulatory and…
Refreshing the Hydrix brand
As an emerging leader in medical technology design, distribution, and investment, we’re thrilled to announce the launch of our refreshed…
Hydrix to sell AI technology that improves identification of structural heart disease
Hydrix Limited (ASX: HYD) (Hydrix or the Company) is pleased to announce that it has entered into a commercial agreement…
Achieving excellence in diverse safety-critical projects
Safety–critical design engineering underpins many of the products and processes used in high-assurance applications. Hydrix’s track record extends to 20+…
Using Code Generation to Accelerate Control Systems Prototyping
Product developers are constantly facing pressure to solve significant, often first-of-type problems, that can soak up large amounts of your…
Developing the GYDER™ HIP SYSTEM
Critical to the success of a hip replacement is ensuring that the artificial hip (acetabular cup) is positioned accurately within…
Halfway through the Heart Hackathon: a brief update on the world’s first student-led Total Artificial Heart design challenge
Hydrix is a foundation sponsor of the Heart Hackathon, a global university student challenge around designing an artificial heart. The…
Monash students race to create cyborg heart in world-first competition
Heart Hackathon organising team members Nina Langer (left) and Taylah Banham (right) A team of Monash University biomedical engineering students…
Preserving your Myocardium
In Australia recently, the deaths of three high profile people, two in their early 50s, shocked the nation and brought…
Developing fit-for-purpose medical devices for critically ill newborns and children
Nash, born at 28 weeks gestation age, benefited from prototype Neonav®, technology. The photo on the right shows Nash, together…
Rugged Portable Power System Wins Award
REDARC GoBlock wins Good Design Awards for Product Design Sport and Lifestyle categoryHydrix is pleased to celebrate the recent launch…
Radiation imaging technology CORIS360 wins two design awards
ANSTO CORIS360 wins Good Design Awards for design and engineering Hydrix is pleased to celebrate that ANSTO’s CORIS360®, an advanced radiation…
Cardiac platform wins Good Design Award
Hydrix, a leader in the design and development of cardiovascular device technologies, is thrilled to announce that its LUDO platform,…
Hydrix joins Ventri Clinical network
Hydrix is pleased to announce it has joined the Ventri Clinical network, Australia’s Gateway for Cardiovascular Medtech Innovation. Facilitated by the Australian…
Introducing LUDO A unique platform to accelerate MCS development
The societal impact of cardiovascular disease is huge. The societal impact of cardiovascular disease is huge. Based on current World…
How to stay approved: Why compliance with changing global post-market requirements matters
Joshan Joy is a Senior Regulatory Affairs Consultant at Hydrix specialising in pre-market and post-market processes and strategy. He has…
Angel Medical Systems Completes First Commercial Implant of the Guardian
ASX ANNOUNCEMENT 02/08/2021 Hydrix Limited (ASX: HYD, ‘Hydrix’ or the ‘Company’) today advises that Angel Medical systems has completed its…
Hydrix announces USA FDA approval for the AngelMed Guardian® device
ASX ANNOUNCEMENT 28/06/2021 AngelMed receives USA FDA approval for the Guardian® device. Hydrix to submit local regulatory approval applications.Key Highlights:…
Experienced medical industry executive Vickie Edwards joins Hydrix
Vickie Edwards Hydrix is pleased to announce that Vickie Edwards has joined as Director Sales & Operations of Hydrix Medical.…
International symposium on the AngelMed Guardian sponsored by Hydrix Medical
Singapore LIVE (SingLIVE) is an annual conference dedicated to cardiovascular intervention in the Asia-Pacific region. Its mission is to contribute…
Developing the CORIS360™, a new radiation imaging solution
Hydrix is proud to have worked with ANSTO on the development of a breakthrough Gamma radiation detection system, the CORIS360™.Described…
Implantation of Next-Generation AngelMed Guardian® commences in US
ASX ANNOUNCEMENT 01/10/2020 Implantation of Next-Generation AngelMed Guardian® commences in USKey Highlights: AngelMed announces first US implant of next-generation AngelMed…
Hydrix and Memphasys awarded 2020 Good Design Awards for the Felix™ ART/IVF technology
Media Release 09/09/2020 Hydrix, a leader in medical device and life sciences product design, engineering and distribution, in collaboration with…